Chinese Journal of Clinical Hepatology 2011 Issue 12 The protective effect of different-time-ischemic preconditioning on the reperfusion injury in fatty livers in rats

The protective effect of different-time-ischemic preconditioning on the reperfusion injury in fatty livers in rats
tang jian jun ; jiang yong ; luo guang hua ; yuan bo

..............page:1308-1311

xin xi dong tai

..............page:1244,1256,1300,1307,1326,后插9

Study of liver pathology in mild ALT-elevated chronic hepatitis B patients with different HBV DNA levels
zhuang lin ; you jing ; lei hua ; li yun li ; kong lei ; wang qing qing ; hu ming fen ; bai bao li

..............page:1278-1281,1284

The association study of the polymorphisms of interferon-inducible genes OAS and the seroconversion of HBsAg and HBeAg in patients with HBeAg positive chronic hepatitis B infection receiving interferon-α and nucleotide analogue combined therapy
ren zuo ; huang yan xiang ; ma li na ; jin zuo ; he zhi min ; zhang xiao dan ; chen xin yue

..............page:1270-1274

Study on the relationship between chemokines and chronic hepatitis C
GUO Dan-dan;ZHANG Yong-Hong;CHEN Xin-yue

..............page:1336-1340

The research advancement of pathogenesis of intrahepatic cholestasis jaundice related to chronic hepatits B
YANG Zong-guo;CHEN Xiao-rong;LIU Cheng

..............page:1323-1326

NK cells and hepatitis C
ZHOU Dong-fang;HU Chao-gang;ZHOU Jun-ying

..............page:1341-1344

Predictors of response and optimized antiviral strategy for patients with chronic hepatitis B
FAN Rong;SUN Jian;HOU Jin-lin

..............page:1239-1244

The correlational study of the relationship between the fibrosin expression in peripheral blood and hepatic fibrosis
li man ; zeng zhen jun ; sun xue hua ; zhu xiao jun ; zhou zhen hua ; gao yue qiu

..............page:1312-1315,1317

New era for management of HCV∶Oral combination of a nucleoside polymerase inhibitor and protease inhibitor
DING Yang;XIA Ting-ting;DOU Xiao-guang

..............page:1266-1269

Interpretation:An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
WANG Mei-xia;NIU Jun-qi

..............page:1255-1256

The short-term dinical effect of dexamethasone therapy in the early stage of viral hepatitis patients with heavy tendency
zhu li hui ; zhang ; li guo qing ; wang zheng gen

..............page:1305-1307

Influence of HBeAg seroconversion on virological relapse in chronic hepatitis B patients on withdrawal of nudeos(t)ide analogues therapy
liang yan xiu ; jiang jian ning ; su ming hua ; guo wen wen ; huang xiao hong ; liu zhi hong ; xie zuo ; fu wu dao ; he li xia ; zhong shao hua

..............page:1275-1277,1290

Detection of hepatitis C virus in the supernatant of human placenta trophoblastic cells and cell lysates
GAO Lu-hua;NIE Qing-he

..............page:1296-1300

Research advancement of antiviral treatment for chronic hepatitis C
QU Si-mai;ZHANG Lin

..............page:1331-1335

Clinical study on telbivudine in preventing mother-to-infant HBV transmission during the late pregnancy
chen xiao qin ; yao zhan cheng ; wu li ping ; chen ming chun ; zhang yan ping ; wu yi

..............page:1282-1284

A case report of hypothyroidism misdiagnosis as hepatitis
TENG Hui-qin

..............page:1316-1317

One case of congenital hepatic fibrosis and hepatitis B virus infection and drug-induced liver injury
WANG Chun-yan;LI Bing

..............page:1318-1319

Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area
liu jin ping ; liu you de ; guo yan mei ; yang shao ping ; lin qing ; lin ling

..............page:1288-1290

HBV mother-to-child transmission block-agreement and controversy
chen wei ; ding yang ; sheng qiu ju ; zuo xiao guang

..............page:1259-1261

Anti-viral therapy in adult patients with acute hepatitis B
ZHANG Yan-mei;DING Xiao-hui

..............page:1327-1330,1344

Clinical analysis of viral hepatitis complicated with myocardial injury
hu ming fen ; li yun li ; bai bao li ; pang xing mei ; zhuang lin

..............page:1301-1304

The hepatitis B virus heterogeneity and the anti-viral response
Zhang Xin-xin

..............page:1262-1265

Clinical effect of pegylated interferon in combination with ribavirin in the retreatment of previous nonresponders or relapsers of chronic hepatitis C
chen xiao yun ; zhang yong hong ; ma li na ; jin zuo ; yu hai bin ; liu ya li ; zhang xiao dan ; guo dan dan ; xu ying xia ; zheng yan hong ; ma bing ; chen xin yue

..............page:1291-1295

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
WANG Mei-xia;NIU Jun-qi

..............page:1245-1254

Re-treatment for relapsed patients after an initial nucleotide(s)analogue therapy in chronic hepatitis B
CHEN Shi-jun;DU Wen-jun

..............page:1257-1258,1269

Recent advancement of telbivudine in the treatment of chronic hepatitis B
wang hai yan ; wang zuo ; peng xiao ming ; liu zuo

..............page:1320-1322,1326

Study on the expression of HLA-DR/CD69 on CD4 +/CD8 + T cells in the treatment of HBeAg-positive chronic hepatitis B with interferon alfa-2b
shi qing feng ; song ji kui ; zhang ying xin ; yuan jian guo ; wang si kui ; li qing fang ; zhao hong kui

..............page:1285-1287,1300